Latest News about NVO
Recent news which mentions NVO
3 Cold Stocks That Can Bounce Back This Week
March 10, 2025
From Motley Fool
Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 10, 2025
From Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
March 06, 2025
From Benzinga
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
March 06, 2025
From Benzinga
From Motley Fool
Why Is Hims & Hers Health Stock Trading Lower On Wednesday?
March 05, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
NVO
From Motley Fool
Why Hims & Hers Stock Rebounded on Wednesday
February 26, 2025
From Motley Fool
6 Stocks to Buy as European Markets Soar
February 26, 2025
From Benzinga
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
From Benzinga
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
February 24, 2025
From Motley Fool
From Benzinga
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
February 23, 2025
From Motley Fool
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
February 21, 2025
From Benzinga
Why Novo Nordisk Stock Popped on Friday
February 21, 2025
From Motley Fool
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
February 19, 2025
Tickers
NVO
From Benzinga
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
February 19, 2025
From Motley Fool
From Benzinga
Novo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks Damages
February 19, 2025
From Benzinga
Digging Into What Hershey and Eli Lilly Told Investors
February 19, 2025
From Motley Fool
3 Hot Stocks That Have Already Doubled in 2025
February 18, 2025
From Motley Fool
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
February 18, 2025
From Benzinga
2 Important Insights From Novo Nordisk's Earnings Call
February 16, 2025
Tickers
NVO
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.